title: [Not Available].
abstract: The use of rituximab in Graves' orbitopathy is appealing but its exact role in the therapeutic arsenal remains to be clarified, and its safety profile also needs to be confirmed on a larger scale.
authors.affiliation: CHRU, université de Lille 2, Clinique endocrinologique Marc-Linquette, 59037 Lille cedex, France. Electronic address: mladsous@free.fr.
authors.forename: Miriam
authors.initials: M
authors.lastname: Ladsous
mesh_terms: D049970:Graves Ophthalmopathy / Q000188:drug therapy*; D006801:Humans; D000069283:Rituximab / Q000627:therapeutic use*
chemical_list: D000069283:Rituximab